• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Apple, Intel, And Some Other Big Stocks Moving Higher On Friday

    10/28/22 10:55:16 AM ET
    $AAPL
    $APPF
    $DXCM
    $EGHT
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $AAPL alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session.

    • Nuvalent, Inc. (NASDAQ:NUVL) shares jumped 62% to $35.60 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC.
    • TAL Education Group (NYSE:TAL) climbed 16.3% to $4.6180 after the company reported better-than-expected Q2 results.
    • 8x8, Inc. (NYSE:EGHT) surged 15% to $3.9189 after the company announced better-than-expected Q2 EPS and sales results.
    • Grand Canyon Education, Inc. (NASDAQ:LOPE) rose 14.5% to $99.97 following strong Q3 results.
    • TESSCO Technologies Incorporated (NASDAQ:TESS) surged 14.5% to $4.98 after the company reported better-than-expected Q2 results.
    • DexCom, Inc. (NASDAQ:DXCM) gained 14.4% to $115.86 after the company reported better-than-expected Q3 results.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) rose 13.7% to $8.80. Scholar Rock Holding 10% owner Invus Public Equities Advisors LLC bought a total of 130,265 shares at an average price of $8.04.
    • PennyMac Financial Services, Inc. (NYSE:PFSI) gained 13.5% to $53.66 after the company reported better-than-expected Q3 sales results.
    • Flagstar Bancorp, Inc. (NYSE:FBC) surged 13.3% to $38.33 after the company announced it has received approval from the Office of the Comptroller of the Currency for the merger with New York Community Bank. The co. also announced a special dividend of $2.50 per share.
    • AppFolio, Inc. (NASDAQ:APPF) gained 12.6% to $119.71 after the company reported better-than-expected Q3 sales results and issued FY22 revenue guidance above analyst estimates.
    • H&E Equipment Services, Inc. (NASDAQ:HEES) surged 11.1% to $36.56. The company posted upbeat quarterly results.
    • Knowles Corporation (NYSE:KN) climbed 10.5% to $14.15 after the company reported better-than-expected Q3 EPS and sales results.
    • Pinterest, Inc. (NYSE:PINS) rose 10.4% to $24.16 after the company reported better-than-expected Q3 results.
    • Gilead Sciences, Inc. (NASDAQ:GILD) rose 9.7% to $76.99 after the company reported better-than-expected Q3 results.
    • Intel Corporation (NASDAQ:INTC) rose 8.5% to $28.50 after the company posted better-than-expected earnings for its third quarter. The company also issued weak guidance for FY22. Intel is focused on cost reductions going forward with a plan for $3 billion in savings in 2023 and cost savings of $8 billion to $10 billion annually by 2025.
    • Apple Inc. (NASDAQ:AAPL) gained 7.3% to $155.42 after the company reported better-than-expected Q4 results and reported year-over-year revenue growth across multiple segments.
    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $APPF
    $DXCM
    $EGHT

    CompanyDatePrice TargetRatingAnalyst
    Gilead Sciences Inc.
    $GILD
    2/11/2026$140.00 → $170.00Buy
    Needham
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Pinterest Inc.
    $PINS
    1/30/2026$24.90Buy → Hold
    HSBC Securities
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    Apple Inc.
    $AAPL
    1/30/2026$250.00 → $267.00Neutral
    Rosenblatt
    Apple Inc.
    $AAPL
    1/30/2026$300.00 → $315.00Buy
    Monness Crespi & Hardt
    Apple Inc.
    $AAPL
    1/30/2026$300.00Hold → Buy
    Maxim Group
    More analyst ratings

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    PennyMac Mortgage Investment Trust Declares First Quarter 2026 Dividends for Its Preferred Shares and Announces 2025 Dividend Tax Information

    PennyMac Mortgage Investment Trust (NYSE:PMT) announced today that its Board of Trustees has declared cash dividends for the first quarter of 2026 on its 8.125% Series A Preferred Shares (NYSE:PMT), its 8.000% Series B Preferred Shares (NYSE:PMT) and its 6.750% Series C Preferred Shares (NYSE:PMT). In accordance with the terms for each preferred series, the dividend information is as follows: Series   Ticker   Annual Dividend Rate   Dividend Per Share   Record Date   Payment Date A PMT PRA 8.125% $0.507813 March 1, 2026* March 16, 2026 B PMT PRB 8.000% $0

    2/12/26 8:00:00 AM ET
    $PFSI
    $PMT
    Finance: Consumer Services
    Finance
    Real Estate Investment Trusts
    Real Estate

    Pennymac Announces Acquisition of Cenlar's Subservicing Business Becoming One of the Largest Mortgage Subservicers

    PennyMac Financial Services, Inc. (NYSE:PFSI) (Pennymac) today announced it has entered into a definitive agreement to acquire the subservicing business of Cenlar Capital Corporation (Cenlar), primarily consisting of subservicing contracts and mortgage servicing operations, in an all-cash transaction for an upfront purchase price of $172.5 million and up to $85 million of contingent consideration payable over three years. Based on Cenlar's current portfolio, Pennymac is expected to add up to $740 billion in unpaid principal balance (UPB) of mortgage loan subservicing and 2 million loans to its servicing portfolio. This expansion will bring Pennymac's total portfolio to over $1 trillion in U

    2/11/26 4:15:00 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    $AAPL
    $APPF
    $DXCM
    $EGHT
    SEC Filings

    View All

    PennyMac Financial Services Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - PennyMac Financial Services, Inc. (0001745916) (Filer)

    2/11/26 4:30:35 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Knowles Corporation

    144 - Knowles Corp (0001587523) (Subject)

    2/10/26 4:05:09 PM ET
    $KN
    Consumer Electronics/Appliances
    Consumer Staples

    Gilead Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)

    2/10/26 4:02:13 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-6) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215973, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-8) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215974, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-9) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/13/2024. Application Category: NDA, Application Number: 215973, Application Classification: Manufacturing (CMC)

    11/15/24 4:36:27 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President of R&D Vaishnaw Akshay was granted 47,021 shares, increasing direct ownership by 8% to 642,788 units (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    2/11/26 6:13:09 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Sinha Vikas was granted 47,021 shares, increasing direct ownership by 8% to 630,266 units (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    2/11/26 6:12:17 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Scientific Officer Qatanani Mo was granted 29,258 shares, increasing direct ownership by 34% to 114,918 units (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    2/11/26 6:11:20 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Gilead Sciences with a new price target

    Needham reiterated coverage of Gilead Sciences with a rating of Buy and set a new price target of $170.00 from $140.00 previously

    2/11/26 7:05:53 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bernstein reiterated coverage on Apple with a new price target

    Bernstein reiterated coverage of Apple with a rating of Outperform and set a new price target of $340.00 from $325.00 previously

    2/10/26 7:51:49 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Pinterest downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Pinterest from Buy to Hold and set a new price target of $24.90

    1/30/26 9:28:34 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Director Akkaraju Srinivas bought $1,181,634 worth of shares (29,599 units at $39.92) and exercised 1,064,804 in-the-money shares at a strike of $7.35 (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    12/16/25 9:07:57 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President & COO Leach Jacob Steven bought $1,001,702 worth of shares (18,200 units at $55.04), increasing direct ownership by 6% to 331,697 units (SEC Form 4)

    4 - DEXCOM INC (0001093557) (Issuer)

    11/10/25 7:13:08 PM ET
    $DXCM
    Medical/Dental Instruments
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Scholar Rock Holding Corporation

    SC 13G/A - Scholar Rock Holding Corp (0001727196) (Subject)

    11/14/24 9:00:58 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Scholar Rock Holding Corporation

    SC 13G/A - Scholar Rock Holding Corp (0001727196) (Subject)

    11/14/24 7:24:55 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Financials

    Live finance-specific insights

    View All

    PennyMac Mortgage Investment Trust Declares First Quarter 2026 Dividends for Its Preferred Shares and Announces 2025 Dividend Tax Information

    PennyMac Mortgage Investment Trust (NYSE:PMT) announced today that its Board of Trustees has declared cash dividends for the first quarter of 2026 on its 8.125% Series A Preferred Shares (NYSE:PMT), its 8.000% Series B Preferred Shares (NYSE:PMT) and its 6.750% Series C Preferred Shares (NYSE:PMT). In accordance with the terms for each preferred series, the dividend information is as follows: Series   Ticker   Annual Dividend Rate   Dividend Per Share   Record Date   Payment Date A PMT PRA 8.125% $0.507813 March 1, 2026* March 16, 2026 B PMT PRB 8.000% $0

    2/12/26 8:00:00 AM ET
    $PFSI
    $PMT
    Finance: Consumer Services
    Finance
    Real Estate Investment Trusts
    Real Estate

    Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend

    Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the company's Board of Directors has declared an increase of 3.8% in the company's quarterly cash dividend, beginning in the first quarter of 2026. The increase will result in a quarterly dividend of $0.82 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 13, 2026. Future dividends will be subject to Board approval. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is commi

    2/10/26 4:02:00 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results

    Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to $14.3 billion for Full Year 2025 Gilead Sciences, Inc. (NASDAQ:GILD) announced today its results of operations for the fourth quarter and full year 2025. "Our fourth quarter and full-year results close out a very strong year for Gilead overall, including the successful U.S. launch of Yeztugo, the world's first twice-yearly HIV prevention therapy, and continued growth for Biktarvy and Descovy," said Daniel O'Day, Gilead's Chairman and Chief Executive Officer. "In 2026, our potential new launches include two cancer therapies and an additional HIV

    2/10/26 4:01:00 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAPL
    $APPF
    $DXCM
    $EGHT
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Pinterest Appoints Kecia Steelman to Board of Directors

    Pinterest, Inc. (NYSE:PINS) today announced that Kecia Steelman, President and Chief Executive Officer of Ulta Beauty, has been appointed to the company's Board of Directors, effective February 16, 2026. "Kecia is a seasoned executive with deep experience leading large-scale businesses and connecting consumers with brands they love," said Bill Ready, Chief Executive Officer of Pinterest. "Her track record of growing global businesses, building omnichannel experiences, and partnering closely with brands will be an asset as we continue to transform Pinterest into the leading visual discovery and AI-powered shopping platform, especially for Gen Z." Steelman joined Ulta Beauty in 2014 and h

    2/9/26 4:50:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance

    Gilead Sciences, Inc. (NASDAQ:GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal & Compliance effective immediately. She will join the company's senior leadership team and report to Chairman and Chief Executive Officer Daniel O'Day. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218926462/en/Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance Ms. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as Senior Vice President leading the Global Legal Business Par

    12/18/25 8:30:00 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care